Articles by Mark Hirschel - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Mark Hirschel

Mark Hirschel


Vendor Notes: The Biovest AutovaxID: Enabling the Promise of Personalized Medicine
July 1, 2007

The AutovaxID is a self-contained, completely enclosed, fully automated hollow fiber bioreactor that permits rapid, efficient scale up of patient-derived cells. It is based on hollow fiber bioreactor technology and is an ideal system for high-density cell culture and the production of monoclonal antibodies or other therapeutic proteins.

ADVERTISEMENT

ADVERTISEMENT

Click here